Fundraising Fox
Relation Rx
Founded 2019 · 141 employees on LinkedIn · 5 known investors
Find your way into Relation Rx
Sign up to see every warm intro you have to Relation Rx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Relation Rx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.
Founders & leadership
DR
David RoblinChief Executive OfficerDavid Roblin is a physician and life sciences executive who previously served as Chief Operating Officer and Chair of Scientific Translation at the Francis Crick Institute and headed European R&D for Pfizer; he also holds board positions at Nxera Pharma and Centauri Therapeutics.
BS
Benjamin SwernerFounder
CR
Charles RobertsFounder
JT
Jake Taylor-KingFounder
Investors · 5
DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M
How we know: the VCSheet dataset · Not right? Tell us
Hitachi Ventureslisted by Hitachi VenturesMunich
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
NVenturesreportedSanta Clara
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Relation Rx do?
- Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.
- Who are Relation Rx's investors?
- Relation Rx's investors include DCVC (Data Collective), Hitachi Ventures, Magnetic Ventures, Raptor Group, NVentures.